Diabetic Macular Edema  >>  Iluvien (fluocinolone acetonide)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Iluvien (fluocinolone acetonide) / Alimera Sci, EyePoint Pharma
NCT02080091: Observational Study to Assess the Effect of Iluvien® in DME Patients Insufficiently Responsive to Available Therapies

Terminated
N/A
25
Europe
Alimera Sciences
Diabetic Macular Edema (DME)
03/15
04/15
IRISS, NCT01998412: Iluvien Registry Safety Study

Unknown status
N/A
559
US
Alimera Sciences
Chronic Diabetic Macular Oedema Considered Insufficiently Responsive to Available Therapies
01/20
01/20

Download Options